Delivery Order SPE2DB22D3019-SPE2DB25FK4GN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,150.56 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on November 20, 2025, with an ultimate completion date of November 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lyrica is a neurological medication commonly used to treat neuropathic pain and...
- The Defense Logistics Agency awarded a delivery order valued at $3,550.74 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Lyrica (pregabalin) is a neurological treatment commonly used to manage...
- The Defense Logistics Agency awarded a delivery order valued at $1,773.39 to AmerisourceBergen Drug Corp for the supply of Lyrica 150 mg capsules (90-count units). This firm fixed price contract, awarded on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. Performance will be executed...
- The Defense Logistics Agency awarded a delivery order valued at $7,459.86 to AmerisourceBergen Drug Corp for Lyrica 50 mg capsules (90-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lyrica is a neurological medication used primarily for neuropathic pain, fibromyalgia, and seizure...
- The Defense Logistics Agency awarded a delivery order valued at $4,757.01 to AmerisourceBergen Drug Corp for the supply of Lyrica 225 mg capsules (90-count units). This non-competitive, firm fixed-price delivery order was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Lyrica (pregabalin) is a neurological medication commonly used to treat neuropathic pain,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lyrica 100 mg capsules (90-count units) with a ceiling value of $8,137.10. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, is scheduled for completion by August 18, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on October 16, 2025, for 100 mg Lyrica (pregabalin) capsules in unit dose packaging (100 count), with a ceiling value of $2,690.65. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 17, 2025, and will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lyrica 100 mg capsules (90-count) with a ceiling value of $1,213.60. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a competitively awarded, non-set-aside contract. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $3,370.10 to AmerisourceBergen Drug Corp for the supply of Lyrica (pregabalin) 50 mg capsules in a 90-count quantity. This competitive award, issued on July 23, 2025, with a completion date of July 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lyrica 100 mg capsules (90-count) at a ceiling value of $5,326.11. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to be completed by September 9, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK4GNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,281.51 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on September 22, 2025, with a completion date of September 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Lyrica (pregabalin) is a neurological treatment used primarily for neuropathic pain, fibromyalgia, and seizure disorders within military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. The company's role as a critical pharmaceutical distributor for federal medical procurement reflects its capability to meet competitive procurement standards while serving defense health needs alongside other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 9/22/25 |